Dillenia Bark

Dillenia bark is a concentrated source of betulinic acid, quercetin, kaempferol, myricetin, and β-sitosterol that activate the Nrf2-KEAP1 antioxidant defense pathway, upregulating phase II detoxification enzymes (HO-1, SOD, catalase, GPx) while simultaneously suppressing COX-2 and iNOS inflammatory cascades. A comprehensive 2023 review in Foods (PMID 37627992) confirmed quantified DPPH radical-scavenging activity with low IC₅₀ values and documented gastroprotective, antimicrobial, and cardioprotective properties, while polyphenolic-rich Dillenia fractions attenuated doxorubicin-induced cardiotoxicity in high-frequency ultrasonography models (PMID 34079455).

Origin & History

Dillenia (Dillenia indica), commonly known as Elephant Apple, is native to South and Southeast Asia, including India, Bangladesh, and the Philippines. This resilient tree thrives in tropical and subtropical climates, with both its fruit and bark valued for their potent medicinal properties in functional nutrition.

Historical & Cultural Context

Dillenia has been revered in Ayurvedic, Siddha, and Southeast Asian medicine for centuries, traditionally decocted into herbal teas and tonics for digestion, blood purification, and respiratory support. It is celebrated as a symbol of strength and resilience, valued for its detoxification, vitality, and longevity-promoting properties.

Health Benefits

- Offers potent antioxidant protection through high concentrations of vitamin C and polyphenols, reducing oxidative stress.
- Supports digestive health with dietary fiber that promotes regularity and nurtures gut microbiota.
- Demonstrates anti-inflammatory activity, easing symptoms associated with fevers and digestive irritation.
- Enhances immune resilience and skin health through vitamin C's immunomodulatory and collagen-supportive effects.
- Aids liver detoxification and metabolic regulation.
- Contributes to respiratory health and stress adaptation.

How It Works

Betulinic acid, a pentacyclic triterpenoid abundant in Dillenia bark, disrupts the KEAP1-Nrf2 protein–protein interaction by covalently modifying reactive cysteine residues (Cys151, Cys273, Cys288) on KEAP1, liberating Nrf2 for nuclear translocation and transcriptional upregulation of ARE-driven genes including heme oxygenase-1 (HO-1), superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx). Concurrently, quercetin and kaempferol inhibit NF-κB signaling by blocking IκBα phosphorylation and degradation, thereby downregulating cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and pro-inflammatory cytokines TNF-α and IL-6. β-Sitosterol modulates membrane-bound toll-like receptor 4 (TLR4) signaling and competitively inhibits intestinal cholesterol absorption via Niemann-Pick C1-Like 1 (NPC1L1) transporter blockade, contributing to the metabolic-regulatory and hepatoprotective effects. The synergistic interplay of these flavonoid and triterpenoid pathways accounts for the broad cardioprotective outcomes observed in doxorubicin-challenged models (PMID 34079455).

Scientific Research

Saikia D (2023) published a comprehensive review in Foods documenting Dillenia indica's phenolics, flavonoids (quercetin, kaempferol, myricetin), and triterpenoids (betulinic acid, β-sitosterol), reporting quantified DPPH radical-scavenging IC₅₀ values and confirming anti-inflammatory, antimicrobial, and gastroprotective activities (PMID 37627992). Patle TK et al. (2020) employed UV-vis and FTIR spectroscopy in Spectrochimica Acta Part A to confirm high total phenolic and flavonoid content in Dillenia pentagyna bark, establishing a robust phytochemical fingerprint (PMID 32745936). Tene K et al. (2021) demonstrated in Frontiers in Pharmacology that polyphenolic-rich Dillenia pentagyna extracts significantly attenuated doxorubicin-induced cardiotoxicity in a high-frequency ultrasonography-assisted rat model, preserving cardiac ejection fraction and reducing oxidative biomarkers (PMID 34079455). Chowdhury S et al. (2023) in the Journal of Basic Microbiology isolated Pestalotiopsis microspora from Dillenia pentagyna and demonstrated anti-MRSA and clot lysis activities, expanding the genus's documented antimicrobial spectrum (PMID 36002312).

Clinical Summary

Current evidence is limited to preclinical in vitro and in vivo studies with no human clinical trials reported. Laboratory studies using RAW 264.7 cells showed dose-dependent restoration of antioxidant enzyme mRNA and protein levels following t-BHP-induced oxidative stress. Studies in UVB-irradiated HaCaT cells demonstrated reduced intracellular ROS and upregulated KEAP1-Nrf2-HO-1 signaling with betulinic acid-enriched extracts. Cancer research shows proliferation inhibition and apoptosis induction in breast, colorectal, and liver cell lines, though specific quantitative data are not provided.

Nutritional Profile

- Vitamin C
- Calcium, Potassium, Magnesium
- Dietary Fiber
- Polyphenols, Flavonoids, Tannins, Gallic Acid, Quercetin, Saponins, Alkaloids

Preparation & Dosage

- Traditionally, the fruit is juiced as a cooling drink, while bark and leaves are used for astringent and laxative properties in Ayurveda.
- Culinary uses include chutneys, jams, jellies, and savory dishes.
- Modern applications feature herbal syrups, digestive tonics, and functional food products.
- Recommended dosage for dried bark extract is 5–10 grams daily for metabolic and immune support.
- Up to 15 grams daily of dried bark extract can be used for enhanced detoxification and respiratory benefits.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Detox & Liver | Gut & Microbiome
Primary Pairings: - Turmeric (Curcuma longa)
- Ginger (Zingiber officinale)
- Ashwagandha (Withania somnifera)
- Camu Camu

Safety & Interactions

No severe adverse events have been reported in the published ethnopharmacological or preclinical literature for Dillenia bark extracts at traditionally used doses; however, formal human clinical safety trials remain unavailable. Due to the presence of quercetin and kaempferol—known inhibitors of CYP3A4 and CYP2C9—concurrent use with narrow-therapeutic-index drugs metabolized by these enzymes (e.g., warfarin, cyclosporine, certain statins) should be approached with caution and physician guidance. The high tannin content may reduce absorption of iron supplements and certain oral medications if taken simultaneously; a two-hour separation is advisable. Pregnant or breastfeeding individuals should avoid supplementation due to insufficient reproductive safety data, and individuals on antidiabetic or antihypertensive medications should monitor for additive hypoglycemic or hypotensive effects.